Literature DB >> 27698680

Status epilepticus: Using antioxidant agents as alternative therapies.

Liliana Carmona-Aparicio1, Cecilia Zavala-Tecuapetla2, María Eva González-Trujano3, Aristides Iii Sampieri4, Hortencia Montesinos-Correa5, Leticia Granados-Rojas1, Esaú Floriano-Sánchez6, Elvia Coballase-Urrutía1, Noemí Cárdenas-Rodríguez1.   

Abstract

The epileptic state, or status epilepticus (SE), is the most serious situation manifested by individuals with epilepsy, and SE events can lead to neuronal damage. An understanding of the molecular, biochemical and physiopathological mechanisms involved in this type of neurological disease will enable the identification of specific central targets, through which novel agents may act and be useful as SE therapies. Currently, studies have focused on the association between oxidative stress and SE, the most severe epileptic condition. A number of these studies have suggested the use of antioxidant compounds as alternative therapies or adjuvant treatments for the epileptic state.

Entities:  

Keywords:  antioxidant agents; epilepsy; epileptic state; oxidative stress

Year:  2016        PMID: 27698680      PMCID: PMC5038440          DOI: 10.3892/etm.2016.3609

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  100 in total

1.  Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

Authors:  David E Naylor; Hantao Liu; Claude G Wasterlain
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

2.  Lithium-pilocarpine status epilepticus in the immature rabbit.

Authors:  K Thompson; C Wasterlain
Journal:  Brain Res Dev Brain Res       Date:  1997-05-20

3.  Hydroalcoholic extract of Emblica officinalis protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory, and neuroprotective intervention.

Authors:  Mahaveer Golechha; Jagriti Bhatia; Shreesh Ojha; Dharmveer Singh Arya
Journal:  Pharm Biol       Date:  2011-07-12       Impact factor: 3.503

4.  Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention.

Authors:  Mahaveer Golechha; Uma Chaudhry; Jagriti Bhatia; Daman Saluja; Dharamvir Singh Arya
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

5.  Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus.

Authors:  E W Lothman; E H Bertram; J Kapur; J L Stringer
Journal:  Epilepsy Res       Date:  1990-07       Impact factor: 3.045

Review 6.  Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development.

Authors:  M A Dichter
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

7.  Protective effects of curcumin against lithium-pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats.

Authors:  Mohammad Ahmad
Journal:  Saudi J Biol Sci       Date:  2013-01-17       Impact factor: 4.219

8.  Patterns of status epilepticus-induced neuronal injury during development and long-term consequences.

Authors:  R Sankar; D H Shin; H Liu; A Mazarati; A Pereira de Vasconcelos; C G Wasterlain
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

9.  Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid-induced seizures.

Authors:  T Dalton; T L Pazdernik; J Wagner; F Samson; G K Andrews
Journal:  Neurochem Int       Date:  1995-07       Impact factor: 3.921

10.  A review of the epidemiology of temporal lobe epilepsy.

Authors:  Jose F Téllez-Zenteno; Lizbeth Hernández-Ronquillo
Journal:  Epilepsy Res Treat       Date:  2011-12-29
View more
  1 in total

1.  Taurine/Pilocarpine Interaction in the Malnourished Rat Brain: A Behavioral, Electrophysiological, and Immunohistochemical Analysis.

Authors:  Elian da Silva Francisco; Rosângela Figueiredo Mendes-da-Silva; Cássia Borges Lima de Castro; Geórgia de Sousa Ferreira Soares; Rubem Carlos Araújo Guedes
Journal:  Front Neurosci       Date:  2019-09-18       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.